Aurora Cannabis (ACB) Common Equity (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Common Equity of $373.2 million for Q1 2026, down 5.58% year-over-year from $395.3 million in Q1 2025, and down 8.34% quarter-over-quarter from $407.2 million in Q4 2025.
Aurora Cannabis (ACB) Common Equity (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Common Equity for 9 consecutive years, with $373.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 5.58% year-over-year to $373.2 million; the TTM figure through Mar 2026 stood at $373.2 million (down 5.58% YoY), while the FY2026 annual figure was $373.2 million, down 8.52% from the prior year.
- Common Equity slipped to $373.2 million in Q1 2026 per ACB's latest filing, from $407.2 million in the prior quarter.
- Across five years, Common Equity topped out at $860.6 million in Q1 2022 and bottomed at $362.9 million in Q1 2023.
- Historically, Common Equity has averaged $445.2 million across 5 years, with a median of $415.4 million in 2024.
- Annual changes were most pronounced in 2022 — Common Equity slumped 71.73% — and 2024, when it grew 16.47%.
- Aurora Cannabis' Common Equity stood at $438.3 million in 2022, then decreased by 6.46% to $410.0 million in 2023, then increased by 6.92% to $438.4 million in 2024, then declined by 7.12% to $407.2 million in 2025, then retreated by 8.34% to $373.2 million in 2026.
- Business Quant data shows ACB's Common Equity at $373.2 million in Q1 2026, $407.2 million in Q4 2025, and $412.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 381.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 373.23 Mn |
| Dec 31, 2025 | 407.18 Mn |
| Sep 30, 2025 | 412.07 Mn |
| Jun 30, 2025 | 424.86 Mn |
| Mar 31, 2025 | 395.27 Mn |
| Dec 31, 2024 | 438.38 Mn |
| Sep 30, 2024 | 427.35 Mn |
| Jun 30, 2024 | 440.40 Mn |
| Mar 31, 2024 | 415.41 Mn |
| Dec 31, 2023 | 410.01 Mn |
| Sep 30, 2023 | 409.55 Mn |
| Jun 30, 2023 | 378.13 Mn |
| Mar 31, 2023 | 362.93 Mn |
| Dec 31, 2022 | 438.33 Mn |
| Sep 30, 2022 | 455.83 Mn |
| Jun 30, 2022 | 519.51 Mn |
| Mar 31, 2022 | 860.60 Mn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | 1.61 Bn |
| Jun 30, 2021 | 1.66 Bn |